Please do not adjust margins
Organic & Biomolecular Chemistry
Page 8 of 13
ARTICLE
Journal Name
(major), 155.5 (minor), 158.77 (minor), 158.81 (major), 159.7 128.1, 128.5, 128.6, 132.8, 133.1, 134.4, 135.9, 140.7, 154.8,
(minor), 160.0 (major), 169.9 (minor), 171.3 (major); TOF- 154.9, 155.1, 155.1, 156.6, 157.0; TOFD-HORI:M10S.10(3m9//Dz0):OB[M01312]A,
HRMS (m/z): [M + H+], calcd for C27H2879BrO6, 527.1064; found, calcd for C38H32O579Br2, 726.0616; found, 726.0602 and calcd
527.1057; calcd for C27H2881BrO6, 529.1044; found, 529.1033.
for C38H32O579Br81Br, 728.0598; found, 728.0577; calcd for
C38H32O581Br2, 730.0585; found, 730.0558.
(E)-1-Styryl-4-(4-vinylphenoxy)benzene (28).16
Mp 158−159 °C; 1H NMR (300 MHz, CDCl3): 5.21 (dd, J = 10.9, Ethyl
(E)-3-(4-(4-(6-bromo-7-methoxychroman-2-
0.6 Hz, 1H), 5.68 (dd, J = 17.6, 0.6 Hz, 1H), 6.70 (dd, J = 17.6, yl)phenoxy)phenyl)acrylate (31b).
10.9 Hz, 1H), 6.98–7.02 (m, 4H), 7.06 (d, J = 6.9 Hz, 2H), 7.23– Following the General Procedure, benzyl acetate 15 (0.052 g,
7.29 (m, 1H), 7.33–7.43 (m, 4H), 7.48–7.52 (m, 4H); 13C{1H} 0.16 mmol), compound 29 (0.093 g, 0.31 mmol), and PTS-Si
NMR (75 MHz, CDCl3): 112.9, 118.9, 119.0, 126.4, 127.5, (0.213 g, 0.17 mmol) were employed to give 31b as a white
1
127.6, 127.8, 127.9, 128.7, 132.7, 133.0, 136.0, 137.4, 156.7, foam (0.049 g, 0.09 mmol, 59%); H NMR (300 MHz, CDCl3):
156.8; TOF-HRMS (m/z): [M + H+], calcd for C22H19O, 299.1430; 1.34 (t, J = 7.1 Hz, 3H), 1.99–2.13 (m, 1H), 2.16–2.24 (m, 1H),
found, 299.1429.
2.69–2.77 (m, 1H), 2.86–2.98 (m, 1H), 3.83 (s, 3H), 4.26 (q, J =
7.1 Hz, 2H), 5.02 (dd, J = 10.1, 2.3 Hz, 1H), 6.35 (d, J = 16.0 Hz,
Ethyl (E)-3-(4-(4-vinylphenoxy)phenyl)acrylate (29).16
1
Mp 58−59 °C; H NMR (300 MHz, CDCl3): 1.34 (t, J = 7.1 Hz, 1H), 6.49 (s, 1H), 6.99 (d, J = 8.7 Hz, 2H), 7.07 (d, J = 8.6 Hz,
3H), 4.26 (q, J = 7.1 Hz, 2H), 5.23 (dd, J = 10.9, 0.6 Hz, 1H), 5.69 2H), 7.24 (s, 1H), 7.41 (d, J = 8.6 Hz, 2H), 7.49 (d, J = 8.7 Hz,
(dd, J = 17.6, 0.6 Hz, 1H), 6.34 (d, J = 16.0 Hz, 1H), 6.71 (dd, J = 2H), 7.66 (d, J = 16.0 Hz, 1H); 13C{1H} NMR (75 MHz, CDCl3):
17.7, 11.0 Hz, 1H), 6.99–7.02 (m, 4H), 7.41 (d, J = 8.6 Hz, 2H), 14.3, 24.1, 29.6, 56.2, 60.4, 77.6, 101.1, 102.0, 115.1, 117.0,
7.49 (d, J = 8.7 Hz, 2H), 7.65 (d, J = 16.0 Hz, 1H); 13C{1H} NMR 118.5, 119.6, 127.7, 129.4, 129.7, 133.0, 136.9, 143.7, 154.9,
(75 MHz, CDCl3): 14.3, 60.4, 113.4, 117.0, 118.4, 119.6, 155.0, 155.9, 159.2, 167.0; TOF-HRMS (m/z): [M + H+], calcd
127.7, 129.3, 129.7, 133.7, 135.9, 143.8, 155.8, 159.3, 167.1; for C27H26O579Br, 509.0958; found, 509.0943; calcd for
TOF-HRMS (m/z): [M + H+], calcd for C19H19O3, 295.1329; C27H26O581Br, 511.0938; found, 511.0921.
found, 295.1331.
Ethyl (E)-3-(4-(4-((E)-styryl)phenoxy)phenyl)acrylate (30).16
Ethyl
(E)-3-(4-(4-(6-bromo-7-methoxy-3-phenylchroman-2-
yl)phenoxy)phenyl)acrylate (31c).
Mp 148−149 °C; 1H NMR (300 MHz, CDCl3): 1.34 (t, J = 7.1 Hz, Following the General Procedure, benzyl acetate 15 (0.071 g,
3H), 4.27 (q, J = 7.1 Hz, 2H), 6.35 (d, J = 16.0 Hz, 1H), 6.97–7.09 0.22 mmol), compound 30 (0.163 g, 0.44 mmol), and PtCl4
(m, 6H), 7.24–7.29 (m, 1H), 7.37 (t, J = 7.5 Hz, 2H), 7.49–7.53 (7.40 mg, 0.02 mmol) were employed to give 31c as a white
1
(m, 6H), 7.67 (d, J = 16.0 Hz, 1H); 13C{1H} NMR (75 MHz, CDCl3): foam (0.092 g, 0.16 mmol, 71%); H NMR (300 MHz, CDCl3):
14.3, 60.4, 117.0, 118.5, 119.8, 126.4, 127.6, 127.7, 128.0, 1.33 (t, J = 7.1 Hz, 3H), 2.94–3.04 (m, 1H), 3.14–3.27 (m, 2H),
128.3, 128.7, 129.4, 129.7, 133.4, 137.2, 143.8, 155.7, 159.3, 3.84 (s, 3H), 4.26 (q, J = 7.1 Hz, 2H), 5.04 (d, J = 9.1 Hz, 1H),
167.1; TOF-HRMS (m/z): [M + H+], calcd for C25H23O3, 6.33 (d, J = 16.0 Hz, 1H), 6.55 (s, 1H), 6.87 (d, J = 8.6 Hz, 4H),
371.1642; found, 371.1642.
(E)-6-Bromo-7-methoxy-2-(4-(4-styrylphenoxy)phenyl)-
chroman (31a).
7.00 (d, J = 6.5 Hz, 2H), 7.12–7.24 (m, 5H), 7.29 (s, 1H), 7.45 (d,
J = 8.7 Hz, 2H), 7.64 (d, J = 16.0 Hz, 1H); 13C{1H} NMR (75 MHz,
CDCl3): 14.3, 32.2, 45.7, 56.2, 60.4, 82.5, 100.9, 102.3, 115.5,
Following the General Procedure, benzyl acetate 15 (0.031 g, 117.0, 118.2, 119.4, 126.9, 128.0, 128.5, 128.7, 129.2, 129.6,
0.09 mmol), compound 28 (0.056 g, 0.19 mmol), and PTS-Si 132.8, 135.2, 140.6, 143.7, 154.7, 155.0, 155.6, 159.3, 167.1;
(0.128 g, 0.103 mmol) were employed to give 31a as a white TOF-HRMS (m/z): [M + H+], calcd for C33H30O579Br, 585.1271;
foam (0.021 g, 0.04 mmol, 44%) along with 31a’ as a white found, 585.1275; calcd for C33H30O581Br, 587.1253; found,
foam (0.0033 g, 0.005 mmol, 5%).
587.1253.
31a: 1H NMR (300 MHz, CDCl3): 2.00–2.24 (m, 2H), 2.70–2.78 6-Bromo-7-methoxy-4-(4-methoxybenzyl)-2-(4-(4-((E)-
(m, 1H), 2.87–2.98 (m, 1H), 3.83 (s, 2H), 5.02 (dd, J = 10.1, 2.2 styryl)phenoxy)phenyl)chroman (31d).
Hz, 1H), 6.50 (s, 1H), 7.00 (s, 1H), 7.03–7.05 (m, 5H), 7.23–7.28 Following the General Procedure, benzyl acetate 21 (0.050 g,
(m, 2H), 7.34–7.41 (m, 4H), 7.48–7.52 (m, 4H); 13C{1H} NMR (75 0.12 mmol), compound 28 (0.071 g, 0.24 mmol), and PTS-Si
MHz, CDCl3): 24.2, 29.6, 56.2, 77.7, 101.1, 102.0, 115.1, (0.16 g, 0.13 mmol) were employed to give 31d as a white
118.9, 119.1, 126.4, 127.5, 127.6, 127.8, 127.9, 128.7, 132.7, foam (0.036 g, 0.06 mmol, 49%) of a 3.7:1 mixture of C4-
1
133.1, 136.1, 137.3, 154.9, 155.1, 156.7, 156.9; TOF-HRMS epimers, favoring the cis C2-C4; H NMR (300 MHz, CDCl3):
(m/z): [M ], calcd for C30H25O379Br, 512.0987; found, 2.15–2.27 (m, 2H, major, minor), 2.34 (dd, J = 5.8, 1.9 Hz, 1H,
512.0977; calcd for C30H25O381Br, 514.0967; found, 514.0950.
major), 2.38 (dd, J = 5.9, 2.0 Hz, 1H, minor), 3.81 (s, 3H, minor),
(31a’): 1H NMR (300 MHz, CDCl3): 1.98 – 2.21 (m, 2H), 2.68 – 3.82 (s, 3H, major), 3.85 (s, 3H, major), 3.88 (s, 3H, minor), 4.14
2.77 (m, 1H), 2.86 –3.04 (m, 2H), 3.16 –3.26 (m, 1H), 3.21 (d, J (dd, J = 5.1, 3.3 Hz, 1H, minor), 4.22 (dd, J = 11.9, 6.0 Hz, 1H,
= 8.5 Hz, 1H), 3.83 (s, 3H), 3.85 (s, 3H), 4.99 (dd, J = 10.1, 2.1 major), 4.99 (dd, J = 10.6, 2.3 Hz, 1H, minor), 5.17 (dd, J = 11.2,
Hz, 1H), 5.04 (d, J = 8.3 Hz, 1H), 6.48 (s, 1H), 6.55 (s, 1H), 6.85 1.6 Hz, 1H, major), 6.53 (s, 1H, major), 6.58 (s, 1H, minor),
(d, J = 8.6 Hz, 2H), 6.92 (d, J = 8.5 Hz, 2H), 7.01 (d, J = 6.9 Hz, 6.85-6.92 (m, 8H, major, minor), 6.97–7.03 (m, 6H, major,
2H), 7.13 (d, J = 8.7 Hz, 4H), 7.17–7.22 (m, 3H), 7.24 (s, 1H), minor), 7.04–7.05 (m, 4H, major, minor), 7.07 (s, 2H, major,
7.29 (s, 1H), 7.34 (d, J = 8.5 Hz, 2H); 13C{1H} NMR (75 MHz, minor), 7.10–7.16 (m, 6H, major, minor), 7.23–7.29 (m, 2H,
CDCl3): 24.2, 29.6, 32.3, 45.7, 56.2, 56.3, 77.7, 82.6, 100.9, major, minor), 7.36 (t, J = 7.5 Hz, 4H, major, minor), 7.43–7.52
101.1, 102.0, 102.2, 115.1, 115.5, 118.7, 118.8, 126.9, 127.5, (m, 10H, major, minor); 13C{1H} NMR (75 MHz, CDCl3): 38.2
8 | J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins